Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2012
09/20/2012WO2012123312A1 Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
09/20/2012WO2012123269A1 Immunogenic compositions and methods for their use
09/20/2012WO2012122969A1 Substituted diphenyl derivatives
09/20/2012WO2012122943A1 Anti-hepatitis b virus x protein polypeptide drug
09/20/2012WO2012122942A1 Polypeptide drug against hepatitis b virus x protein
09/20/2012WO2012122941A1 Polypeptide drug against hepatitis b virus x protein
09/20/2012WO2012122931A1 Paecilomyces tenuipes strain and applications thereof
09/20/2012WO2012122921A1 Salt form of hydroxyphenylalanine kinase inhibitor
09/20/2012WO2012122891A1 Oxime-containing amino derivative, pharmaceutical composition, preparation method and use thereof
09/20/2012WO2012122865A2 Pharmaceutically acceptable salt of (e)-n-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolyl]-3-[(2r)-1-methylpyrrolidin-2-yl]prop-2-enamide, preparation method therefor, and medical use thereof
09/20/2012WO2012122649A1 Recombinant orf virus
09/20/2012WO2012122645A1 Methods of treating cancer by inhibition of dna repair proteins
09/20/2012WO2012122642A1 Uses of modified elr-cxc chemokine g31p to treat cancer
09/20/2012WO2012122640A1 Compositions, diagnostic methods using epithelial extracellular matrix proteins
09/20/2012WO2012097173A3 Substituted benzoazepines as toll-like receptor modulators
09/20/2012WO2012082862A3 Androgen receptor inhibitors and methods of use thereof
09/20/2012WO2012082436A3 Modulators of histone methyltransferase, and methods of use thereof
09/20/2012WO2012075500A3 7-deazapurine modulators of histone methyltransferase, and methods of use thereof
09/20/2012US20120238728 Multivalent antibodies and uses therefor
09/20/2012US20120238634 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators
09/20/2012US20120238628 Dihydronaphthalene and naphthalene derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
09/20/2012US20120238617 Microrna expression signature in peripheral blood of patients affected by hepatocarcinoma or hepatic cirrhosis and uses thereof
09/20/2012US20120238604 Cytotoxic compounds
09/20/2012US20120238601 Treatment of cancer
09/20/2012US20120238599 Heterocyclic compounds as mek inhibitors
09/20/2012US20120238597 Inhibiting EPH B-3 Kinase
09/20/2012US20120238595 Therapeutic compounds
09/20/2012US20120238593 Heterocyclic compounds and uses thereof
09/20/2012US20120238587 Novel pyridopyrimidine derivatives and use thereof
09/20/2012US20120238582 Quinazoline derivatives
09/20/2012US20120238577 Prostaglandin transporter inhibitors and uses thereof
09/20/2012US20120238576 Triazine Derivatives and their Therapeutical Applications
09/20/2012US20120238575 Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones
09/20/2012US20120238571 Indazole derivatives as pi 3-kinase
09/20/2012US20120238570 Inhibitors of the hedgehog pathway
09/20/2012US20120238568 Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use
09/20/2012US20120238567 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
09/20/2012US20120238564 Imidazo pyrazines
09/20/2012US20120238559 Novel compounds
09/20/2012US20120238556 Crystalline methylthioninium chloride hydrates
09/20/2012US20120238550 Compound
09/20/2012US20120238549 Nuclear Hormone Receptor Modulators
09/20/2012US20120238548 1,4-oxazepines as bace1 and/or bace2 inhibitors
09/20/2012US20120238545 Tricyclic pyrazol amine derivatives
09/20/2012US20120238542 Aminopyrazoloquinazolines
09/20/2012US20120238541 Pharmaceutical compounds
09/20/2012US20120238540 Amino-pyrimidine compounds as inhibitors of ikk epsilon and/or tbk1
09/20/2012US20120238538 Macrocyclic amides, pharmaceutical compositions, preparation methods and uses thereof
09/20/2012US20120238534 Oral suspension of prednisolone acetate
09/20/2012US20120238533 (Heteroarylmethyl) Thiohydantoins as anticancer drugs
09/20/2012US20120238532 Treatment of human osteosarcoma
09/20/2012US20120238529 Triptolide prodrugs
09/20/2012US20120238526 Aconitine compounds, compositions, uses, and preparation thereof
09/20/2012US20120238518 Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
09/20/2012US20120238513 Method for inhibiting activation of macrophages
09/20/2012US20120238510 Crystalline form of benzylbenzene sglt2 inhibitor
09/20/2012US20120238507 Alpha helical mimics, their uses and methods for their production
09/20/2012US20120238501 Modulation Of Osteoclast Differentiation
09/20/2012US20120238500 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
09/20/2012US20120238494 Methods for reducing gnrh-positive tumor cell proliferation
09/20/2012US20120238488 Compounds and methods for treating neoplasia
09/20/2012US20120237619 Combretum laurifolium mart. extract and methods of extracting and using such extract
09/20/2012US20120237615 Pharmaceutical compositions of o-nitro compounds
09/20/2012US20120237614 Peptide able to disrupt the protein complex between the his273 mutaded p53 protein and the oncosuppressive p73 protein in tumor cells and therapeutic uses thereof
09/20/2012US20120237605 Multifunctional Metal Nanoparticles Having A Polydopamine-Based Surface and Methods of Making and Using the Same
09/20/2012US20120237602 Press-coated orally-disintegrating tablets
09/20/2012US20120237595 Methods for treating amyloidosis using 4-(amino)-2-(2,6-dioxo(3-piperidyl))- isoindoline-1,3-dione
09/20/2012US20120237593 Formulations of Guanylate Cyclase C Agonists and Methods of Use
09/20/2012US20120237590 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
09/20/2012US20120237569 Emulsified composition for dilution and cancer vaccine composition
09/20/2012US20120237566 Inhibiting stomach-acid release, reducing inflammation and preventing and treating cancer: compositions and methods of use
09/20/2012US20120237565 Pegylated polyplexes containing two or more different polymers for polynucleotide delivery
09/20/2012US20120237563 Controlled-release formulations of anabaseine compounds and uses thereof
09/20/2012US20120237562 Antibiotic drug delivery and potentiation
09/20/2012US20120237553 Process to Obtain a Homeopathic Medicament and Use Thereof
09/20/2012US20120237552 Peptoid Agonists of Nerve Growth Factor and Their Use as Medicaments
09/20/2012US20120237551 Immune response modifier formulations containing oleic acid and methods
09/20/2012US20120237535 Therapeutic Compositions For The Treatment of HPV-Induced Diseases
09/20/2012US20120237533 Compositions and Methods for Inducing Apoptosis in Prostate Cancer Cells
09/20/2012US20120237532 Pharmaceutical formulation containing immunoglobulin
09/20/2012US20120237531 Topoisomerase inhibitors
09/20/2012US20120237528 Human Tissue Factor Antibody and Uses Thereof
09/20/2012US20120237524 Met inhibitors for enhancing radiotherapy efficacy
09/20/2012US20120237522 Anticancer agent comprising anti-pd-1 antibody or anti-pd-l1 antibody
09/20/2012US20120237521 Compositions and methods for increasing muscle growth
09/20/2012US20120237520 Boris isoforms and methods of detecting and treating disease
09/20/2012US20120237518 Anti-trop-2 antibody
09/20/2012US20120237516 Compositions and methods relating to anti-igf-1 receptor antibodies
09/20/2012US20120237514 Vascular endothelial cell growth factor antagonists and uses thereof
09/20/2012US20120237510 Anti-NKG2A Antibodies and Uses Thereof
09/20/2012US20120237509 Anti-Mesothelin Antibodies
09/20/2012US20120237508 Fused amino pyridine as hsp90 inhibitors
09/20/2012US20120237507 Monovalent Antigen Binding Proteins
09/20/2012US20120237506 Antigen Binding Proteins
09/20/2012US20120237502 Method for treating breast cancer and ovarian cancer
09/20/2012US20120237497 Compositions and methods for producing clostridial collagenases
09/20/2012US20120237486 Mesenchymal stem cell and the method of use thereof
09/20/2012US20120237482 Methods for treatment of neurological disorders by modulation of microglial activation
09/20/2012US20120237481 Incorporation of the B18R gene to enhance antitumor effect of virotherapy
09/20/2012US20120237480 2'allene-substituted nucleoside derivatives
1 ... 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 ... 2211